Cargando…
Age-related macular degeneration: Beyond anti-angiogenesis
Recently, anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration have been developed. These agents, originally developed for their anti-angiogenic mechanism of action, probably also work through an anti-permeability effect in preventing or reducing the amo...
Autor principal: | Kent, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888498/ https://www.ncbi.nlm.nih.gov/pubmed/24426775 |
Ejemplares similares
-
Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
por: Prea, Selwyn M., et al.
Publicado: (2015) -
A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration
por: Heloterä, Hanna, et al.
Publicado: (2022) -
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019) -
Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010) -
Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)